InVision Medical Technology
AI Diagnosis of Heart Disease
At InVision, we use AI to help streamline the interpretation of ultrasounds and identify diseases that may have been missed by human readers. Our models have been tightly integrated into the clinical workflow to allow easy usage by clinicians. Our work has previously been peer-reviewed and published in several top medical venues, including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), JAMA Cardiology (2022). Results from our blinded and randomized clinical trial on evaluating cardiac function have also been recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology.
- Website
- invisionmedtech.com
- City
- San Francisco
- Country
- United States
- YC batch
- Summer 2022
- Team
- 2 people
- Stage
- Early stage
- AI-native
- Yes
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run invisionmedtech.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to InVision Medical Technology across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with InVision Medical Technology's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
